Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Med Onc / Hem Consultants

2 abstracts

Abstract
Correlation of baseline ENPP1 and cGAS expression in advanced solid tumors with intratumoral immune activation and clinical outcomes after treatment with the first-in-class oral ENPP1 inhibitor RBS2418, alone or in combination with pembrolizumab.
Org: HonorHealth Research and Innovation Institute, Center for Cancer and Blood Disorders, Med Onc / Hem Consultants,
Abstract
Combined pulsed radiotherapy (QUAD shot regimen) with immune checkpoint inhibition (ICI) to enhance immune response for LAHNSCC in patients considered ineligible for curative intent therapy.
Org: Grandview Cancer Center, Helen F. Graham Cancer Center and Research Institute, Newark, DE, Thomas Jefferson University Hospital, Christiana Care Health System, Med Onc / Hem Consultants,